Viking Therapeutics

VKTX • NASDAQ • Stock Fundamentals

Viking Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brian Lian, with a market cap of $3.3B.

Market Cap$3.3B

Employees30.0

CEOBrian Lian

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsApr 29, 2026 · 1 month 17 days agoQ1 2026

Next EarningsJul 29, 2026 · in a monthAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Viking Therapeutics

Viking Therapeutics (VKTX) has a market capitalization of $3.3B and trades on NASDAQ.

Viking Therapeutics has approximately 30 employees.